Vasomedical Gains CHF Indication For Noninvasive Counterpulsation Therapy
This article was originally published in The Gray Sheet
Executive Summary
A new congestive heart failure indication could create a 10-fold increase in the number of patients eligible for Vasomedical's EECP counterpulsation therapy system